Marie A BadalamenteSummaryAffiliation: State University of New York Country: USA Publications
| Collaborators
|
Detail Information
Publications
Efficacy and safety of injectable mixed collagenase subtypes in the treatment of Dupuytren's contractureMarie A Badalamente
Department of Orthopedics, State University of New York at Stony Brook, Health Science Center, Stony Brook, NY 11794 8181, USA
J Hand Surg Am 32:767-74. 2007..To further evaluate the efficacy and safety of an injectable mixed subtype collagenase for the treatment of Dupuytren's contracture (DC)...
Injectable collagenase clostridium histolyticum for Dupuytren's contractureLawrence C Hurst
Department of Orthopaedics, SUNY at Stony Brook, Health Science Center, Level 18, Rm 020, Stony Brook, NY 11794 8181, USA
N Engl J Med 361:968-79. 2009..Injection of collagenase clostridium histolyticum, an office-based, nonsurgical option, may reduce joint contractures caused by Dupuytren's disease...
Collagen as a clinical target: nonoperative treatment of Dupuytren's diseaseMarie A Badalamente
Department of Orthopaedics, State University of New York at Stony Brook, Health Science Center, Stony Brook, NY 11794, USA
J Hand Surg [Am] 27:788-98. 2002..The findings of our study may lead to simpler and less invasive nonoperative treatments of joint limitation in which collagen plays a major pathologic role...
